Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu
Grade C

Healthicare review

Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.

Semaglutide: $126/mo monthly; $107.10/mo quarterly; tirzepatide: $144/mo monthly; $122.40/mo quarterly. Quarterly totals are $321.30 and $367.20; advertised prices include the listed care and shipping fees and exclude California.

$126/mo
Flat price · every dose
Consult Medication Shipping Coaching
See plans at Healthicare
  • Confirm HSA / FSA coverage
  • Public signup path reviewed
  • Confirm your total cost
Compare alternatives ↓

Healthicare at a glance

Semaglutide
$126/mo monthly; $107.10/mo quarterly
Tirzepatide
$144/mo monthly; $122.40/mo quarterly
Coverage
Claims 44 states; excludes CA, NV, NJ, NC, TX, MA, MS, NH, WV, DE — though 50 minus those 10 is 40, not 44, a real arithmetic mismatch on its own page
Brand-name
Compounded only

How we scored Healthicare

Every factor comes from Healthicare's own published pricing, disclosures and oversight, and the six combine into the 50/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.

Postpartum & breastfeeding guidance20/100 · Weak

No postpartum or breastfeeding framing — a generic weight program.

PCOS & hormonal fit55/100 · Weak

Thin on the hormonal picture that drives many mothers' weight.

Clinical oversight & labs62/100 · Weak

Oversight and lab support fall short of the best on our list — the review below says exactly where.

True monthly cost55/100 · Weak

Cost is unpredictable or sits at the premium end.

Ongoing support60/100 · Weak

Support is thin once the prescription ships.

Cancellation fairness55/100 · Weak

Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.

How we checked this review

Semaglutide: $126/mo monthly; $107.10/mo quarterly; tirzepatide: $144/mo monthly; $122.40/mo quarterly. Quarterly totals are $321.30 and $367.20; advertised prices include the listed care and shipping fees and exclude California.

What to expect when you sign up

We walked Healthicare's public signup — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.

  1. 1Homepage and /weight-loss list both compounded molecules with two commitment tiers each, both explicitly stated as "same price every dose" — pricing is visible with no account or intake required
  2. 2A named physician (Dr. Jonah Mink, Beluga Health) and a named compounding pharmacy (F&F Pharmacies Inc.) appear directly on the page, along with QA/lot-tracking language for every compounded batch
  3. 3An itemized cost breakdown is shown for context: $60 doctor consultation, $30 prescription preparation, $10 shipping & handling, $25 telehealth platform fee, and a $44 "HealthiCare Service" line

What we noticed

  • Its own "44 states" claim doesn't reconcile with its own 10-state exclusion list — 50 minus 10 is 40, not 44 — a real inconsistency we're flagging rather than picking whichever number reads better
  • Separately claims its medical team is "certified in all 50 states to practice medicine," which is a different claim from pharmacy-dispensing eligibility; being able to see a prescriber doesn't guarantee the pharmacy can ship to you
  • The itemized fee breakdown shown on the page doesn't cleanly add up to the $174 headline

Pricing

MedicationPricePlan
Compounded semaglutide$126Monthly Plan (no commitment)$126 billed monthly, including listed medical, shipping and platform fees; California excluded.
Compounded semaglutide$107.13-Month Plan (billed quarterly)$321.30 billed every three months, equivalent to $107.10/month; California excluded.
Compounded tirzepatide$144Monthly Plan (no commitment)$144 billed monthly, including listed medical, shipping and platform fees; California excluded.
Compounded tirzepatide$122.43-Month Plan (billed quarterly)$367.20 billed every three months, equivalent to $122.40/month; California excluded.

Swipe the table to see plan details →

Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Healthicare's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.

What we like

  • Semaglutide: $126/mo monthly; $107.10/mo quarterly; tirzepatide: $144/mo monthly; $122.40/mo quarterly.
  • Names a real, checkable physician (Dr. Jonah Mink, Beluga Health) and a named compounding pharmacy (F&F Pharmacies Inc.), with stated QA and lot-tracking to the patient file

The caveats

  • Quarterly totals are $321.30 and $367.20; advertised prices include the listed care and shipping fees and exclude California.
  • Its own "44 states" claim doesn't arithmetically reconcile with its own 10-state exclusion list (50 minus 10 is 40, not 44) — confirm your specific state directly rather than trust either number
  • No mention anywhere of pregnancy, breastfeeding, postpartum recovery, or PCOS
  • Compounded medications only — not FDA-approved finished products, no brand option, and no oral form

Current monthly and quarterly choices are distinct

Healthicare lists compounded semaglutide at $126 billed monthly and tirzepatide at $144. The three-month alternatives cost $321.30 and $367.20, equivalent to $107.10 and $122.40 per month across their terms. The lower figures are quarterly averages rather than independent monthly payments. Compare the actual monthly option if limiting the initial commitment matters, or keep the full quarterly charge visible when evaluating the longer plan. Both the medication and the payment term should describe the same proposed order.

The advertised prices include the listed medical, shipping, and platform fees and exclude California. Earlier higher $174 and $264 monthly amounts should not replace the current product offer. Ask whether your prescribed dose and quantity fit the selected plan and how a change is handled during a prepaid term. A clear price ladder is useful, but it does not establish a refund for unused medication or guarantee that the clinical plan will remain unchanged for the full purchase period.

Coverage information needs an individual answer

Healthicare has claimed service in 44 states while publishing a ten-state exclusion list, which would leave 40 states if applied literally to the 50-state total. The current pricing also explicitly excludes California. Those pieces of information should not be combined into a newly invented coverage map. Confirm the actual service and medication in your state before starting, including where the consultation will occur and where the prescription is delivered. The company's inconsistent count cannot substitute for that answer.

The footer identifies Sunshine Health Studios Inc. and describes the program as powered by Bask. Dr. Jonah Mink of Beluga Health is named, and F&F Pharmacies Inc. is identified as a compounding pharmacy. Those disclosures help distinguish the platform, clinical, and dispensing roles. Confirm the actual professional and pharmacy serving your order rather than assuming a named person handles every patient. A technology-platform name does not identify who is responsible for a particular clinical decision or product concern.

Quality claims should stay connected to the prescription

Healthicare describes quality-assurance procedures and lot tracking to the patient file. Ask how to obtain the pharmacy and batch information for the medication actually supplied. A tracking claim can provide useful documentation without proving an outcome for every prescription. Compounded drugs are not FDA approved. Familiar ingredient names, a named physician, and shipping included in the price do not establish equivalence to an approved branded medicine or demonstrate specialist expertise in every medical circumstance.

Request the full formulation, concentration, quantity, storage, and written instructions. If you are switching from another service, a clinician should review the existing treatment rather than asking you to transfer injection volumes or directions independently. Also clarify how follow-up works: whether appointments are scheduled, how messaging is routed, and whether another clinical service costs extra. The inclusion of medical fees is useful only when the scope of the care being purchased is understandable.

The quarterly discount has practical limits

Before prepaying, ask how to cancel, when notice must arrive, and what happens to remaining shipments if treatment changes. Stopping a future renewal is different from recovering a charge already made. The agreement should explain both the payment authorization and the point at which medication becomes nonrefundable. A quarterly average lowers the arithmetic cost but does not automatically make it the better choice for someone uncertain about a new service or formulation.

Healthicare may appeal to someone who wants named clinical and pharmacy partners and a readable monthly-versus-quarterly comparison. Its public information does not establish substantive pregnancy, breastfeeding, postpartum, or PCOS guidance, so relevant circumstances need direct discussion. Resolve state eligibility first, then obtain the actual prescription, complete bill, and continuing-care terms. The $126 and $144 monthly options and larger prepaid totals are useful financial facts when kept alongside the coverage inconsistency and practical scope of support.

The bottom line for mothers

Best for: Readers who can compare the full payment commitment and confirm the renewal amount before choosing a plan.

Alternatives to Healthicare

These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.

  • CoreAge RxFeatured partner

    CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.

    Visit CoreAge Rx
  • A low-entry, all-in compounded program with both molecules, one price at every dose and a clean cancel-anytime policy — appealing, though the 'from' price isn't explained and the outcome claims are unverified marketing.

    Visit yourEra
  • Real pre-intake pricing on its GLP-1 pages ($149/mo semaglutide-class B12 combo, $249/mo tirzepatide billed quarterly) inside a much broader TRT-and-men's-health platform — with a strict cancellation policy that refuses cancellations inside 48 hours of a renewal.

    Visit Peter MD

Providers like Healthicare

Keep comparing Healthicare

Healthicare, answered

Does Healthicare's price go up as my dose increases?
Semaglutide: $126/mo monthly; $107.10/mo quarterly; tirzepatide: $144/mo monthly; $122.40/mo quarterly. Quarterly totals are $321.30 and $367.20; advertised prices include the listed care and shipping fees and exclude California.
Is Healthicare's "44 states" coverage claim accurate?
The math doesn't hold up on its own page. Healthicare names 10 states it explicitly cannot serve — California, Nevada, New Jersey, North Carolina, Texas, Massachusetts, Mississippi, New Hampshire, West Virginia and Delaware — and 50 minus 10 is 40, not 44. We're flagging the inconsistency rather than picking whichever number sounds better; confirm directly with Healthicare before assuming your state is covered.
Who actually prescribes and fills the prescription at Healthicare?
Beluga Health, through physician Dr. Jonah Mink, handles the medical side; F&F Pharmacies Inc. compounds and ships the medication, with quality-assurance and lot-tracking language stated on Healthicare's own page. Both are named directly rather than left anonymous.

Pricing, states and verification reflect Healthicare's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers